ILiAD Biotechnologies

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

Leyden Labs

The company develops intranasal antibody sprays to protect people against respiratory viruses by stopping infection at the nasal mucosa.

InCarda Therapeutics

This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

ReViral

This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.

GlycoVaxyn

This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

Vaxdyn

Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.